<DOC>
	<DOC>NCT03056534</DOC>
	<brief_summary>R3 Delta Post-Approval Study U.S.</brief_summary>
	<brief_title>R3 Delta Ceramic Acetabular System PAS U.S.</brief_title>
	<detailed_description>Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - US The R3 Ceramic Acetabular System is indicated for use in skeletally mature patients requiring primary total hip arthroplasty due to non-inflammatory arthritis (degenerative joint disease) such as osteoarthritis, avascular necrosis, or traumatic arthritis. The expected timeline for the study is a total of approximately 5 years: 6 months for site initiation, 12 months for subject enrollment, 3 years until the last subject enrolled has reached the 3 year follow-up interval.</detailed_description>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Patient is 1875 years old and he/she is skeletally mature Patient requires primary total hip arthroplasty due to noninflammatory degenerative joint disease (degenerative joint disease) such as osteoarthritis, avascular necrosis, or traumatic arthritis. Patient has met an acceptable preoperative medical clearance and is free from or treated for cardiac, pulmonary, hematological, etc., conditions that would pose excessive operative risk Patient is willing and able to participate in required followup visits and to complete study procedures and questionnaires Patient has consented to participating in the study by signing the IRB/EC approved informed consent form Patients with insufficient quantity or quality of bone support; metabolic bone disease; osteoporosis Patients with neurological or muscular conditions that would place extreme load or instability upon the hip joint Patients with active joint infections or chronic systemic infection Obese patients where obesity is defined as BMI &gt; 40 Skeletal immaturity Known allergy to implant materials</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Primary Total Hip Arthroplasty</keyword>
	<keyword>Non-Inflammatory Arthritis</keyword>
	<keyword>Degenerative Joint Disease</keyword>
	<keyword>R3 Delta Ceramic Acetabular Insert</keyword>
</DOC>